- Home
- ASAN vs XENE Comparison
ASAN vs XENE Comparison
Compare ASAN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASAN
- XENE
- Stock Information
- Founded
- ASAN 2008
- XENE 1996
- Country
- ASAN United States
- XENE Canada
- Employees
- ASAN N/A
- XENE N/A
- Industry
- ASAN Retail: Computer Software & Peripheral Equipment
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- ASAN Technology
- XENE Health Care
- Exchange
- ASAN Nasdaq
- XENE Nasdaq
- Market Cap
- ASAN 3.3B
- XENE 2.9B
- IPO Year
- ASAN 2020
- XENE 2014
- Fundamental
- Price
- ASAN $14.38
- XENE $37.76
- Analyst Decision
- ASAN Hold
- XENE Strong Buy
- Analyst Count
- ASAN 14
- XENE 11
- Target Price
- ASAN $17.04
- XENE $52.73
- AVG Volume (30 Days)
- ASAN 4.4M
- XENE 641.2K
- Earning Date
- ASAN 09-03-2025
- XENE 11-11-2025
- Dividend Yield
- ASAN N/A
- XENE N/A
- EPS Growth
- ASAN N/A
- XENE N/A
- EPS
- ASAN N/A
- XENE N/A
- Revenue
- ASAN $756,419,000.00
- XENE $7,500,000.00
- Revenue This Year
- ASAN $10.81
- XENE N/A
- Revenue Next Year
- ASAN $8.50
- XENE $207.88
- P/E Ratio
- ASAN N/A
- XENE N/A
- Revenue Growth
- ASAN 9.74
- XENE N/A
- 52 Week Low
- ASAN $11.08
- XENE $26.74
- 52 Week High
- ASAN $27.77
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- ASAN 54.48
- XENE 55.91
- Support Level
- ASAN $13.11
- XENE $35.60
- Resistance Level
- ASAN $14.02
- XENE $37.99
- Average True Range (ATR)
- ASAN 0.68
- XENE 1.06
- MACD
- ASAN 0.03
- XENE -0.37
- Stochastic Oscillator
- ASAN 48.94
- XENE 50.94
About ASAN Asana Inc.
Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.